The genetic and regulatory architecture of ERBB3-type 1 diabetes susceptibility locus

Molecular and Cellular Endocrinology

Volumn 419, Issue , 2016, Pages 83-91

  Kaur, Simranjeet ^a,b   Mirza, Aashiq H ^a,b,c   Brorsson, Caroline A ^a   Fløyel, Tina ^a   Størling, Joachim ^a   Mortensen, Henrik B ^a,b   Pociot, Flemming ^a,b,c   Aanstoot, Henk Jan ^d   de Beaufort, Carine E ^e   Cameron, Fergus ^f   Castano, Luis ^g   Dorchy, Harry ^h   Fisher, Lynda ⁱ   Kaprio, Eero ^j   Lange, Karin ^k   Neu, Andreas ^l   Njolstad, Pal R ^m,n   Phillip, Moshe ^o   Robert, Jean ^p   Urukami, Tatsuhiko ^q   Barrett, Tim ^r   Chiarelli, Francesco ^s   Danne, Thomas ^t   Hoey, Hilary ^u   Kocova, Mirjana ^v   Mortensen, Henrik ^b   Schoenle, Eugen ^w   Swift, Peter ^x   Vanelli, Maurizio ^y   Åman, Jan ^z   more..

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d Center for Pediatric and Adolescent Diabetes Care and Research   (Netherlands)

^e CENTRE HOSPITALIER DE LUXEMBOURG   (Luxembourg)

^f ROYAL CHILDREN'S HOSPITAL   (Australia)

^g UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^h HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

ⁱ CHILDREN S HOSPITAL LOS ANGELES   (United States)

^j PEIJAS HOSPITAL   (Finland)

^k HANNOVER MEDICAL SCHOOL   (Germany)

^l UNIVERSITY OF TÜBINGEN   (Germany)

^m UNIVERSITY OF BERGEN   (Norway)

ⁿ HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^o National Center for Childhood Diabetes   (Israel)

^p HÔPITAL NECKER ENFANTS MALADES   (France)

^q NIHON UNIVERSITY   (Japan)

^r UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^s Policlinico   (Italy)

^t KINDERKRANKENHAUS AUF DER BULT   (Germany)

^u ADELAIDE AND MEATH HOSPITAL   (Ireland)

^v Clinical Center Skopje   (Macedonia)

^w UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^x LEICESTER ROYAL INFIRMARY   (United Kingdom)

^y Centro di Diabetologia   (Italy)

^z ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

more..

Author keywords

Apoptosis; Beta cell; CTCF; ERBB3; LncRNAs; Type 1 diabetes

Indexed keywords

CYTOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR 3; ERBB3 PROTEIN, HUMAN; LONG UNTRANSLATED RNA;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE DURATION; DOWN REGULATION; ERBB3 GENE; FEMALE; GENE; GENE EXPRESSION; GENE LOCUS; GENE SILENCING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLIC REGULATION; PANCREAS ISLET CELL; PRIORITY JOURNAL; ANIMAL; CELL CULTURE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; METABOLISM; PANCREAS ISLET BETA CELL; RAT; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; APOPTOSIS; CELLS, CULTURED; CHILD; CROSS-SECTIONAL STUDIES; CYTOKINES; DIABETES MELLITUS, TYPE 1; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN-SECRETING CELLS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RATS; RECEPTOR, ERBB-3; RNA, LONG NONCODING;

EID: 84949729662     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2015.10.002     Document Type: Article

References (54)

1. Achenbach P., Hummel M., Thümer L., et al. Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children. Diabetologia 2013, 56:1615-1622.
2. Andersen M.L.M., Rasmussen M.A., Pörksen S., et al. Complex multi-block analysis identifies new immunologic and genetic disease progression patterns associated with the residual β-cell function 1 year after diagnosis of type 1 diabetes. PLoS One 2013, 8:e64632.
3. Andersson R., Gebhard C., Miguel-Escalada I., et al. An atlas of active enhancers across human cell types and tissues. Nature 2014, 507:455-461.
4. Ardestani A., Paroni F., Azizi Z., et al. MST1 is a key regulator of beta cell apoptosis and dysfunction in diabetes. Nat. Med. 2014, 20:385-397.
5. Barker J.M., Triolo T.M., Aly T.A., et al. Two single nucleotide polymorphisms identify the highest-risk diabetes HLA genotype: potential for rapid screening. Diabetes 2008, 57:3152-3155.
6. Barrett J.C., Clayton D.G., Concannon P., et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat. Genet. 2009, 41:703-707.
7. Baselga J., Swain S.M. Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. Nat. Rev. Cancer 2009, 9:463-475.
8. Bonifacio E., Krumsiek J., Winkler C., et al. A strategy to find gene combinations that identify children who progress rapidly to type 1 diabetes after islet autoantibody seroconversion. Acta Diabetol. 2014, 51:403-411.
9. Boyle A.P., Hong E.L., Hariharan M., et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 2012, 22:1790-1797.
10. Brorsson C.A., Pociot F. Shared genetic basis for type 1 diabetes, islet autoantibodies, and autoantibodies associated with other immune-mediated diseases in families with type 1 diabetes. Diabetes Care 2015, 38(Suppl. 3):1-6. Type 1 Diabetes Genetics Consortium. 10.2337/dcS15-2003.
11. Bruno A.E., Li L., Kalabus J.L., et al. miRdSNP: a database of disease-associated SNPs and microRNA target sites on 3'UTRs of human genes. BMC Genomics 2012, 13:44.
12. Burton P.R., Clayton D.G., Cardon L.R., et al. Genome-wide association study of 14,000 cases of seven common diseases and 3000 shared controls. Nature 2007, 447:661-678.
13. Chen H., Tian Y., Shu W., et al. Comprehensive identification and annotation of cell type-specific and ubiquitous CTCF-binding sites in the human genome. PLoS One 2012, 7:e41374.
14. Cusanovich D.A., Pavlovic B., Pritchard J.K., Gilad Y. The functional consequences of variation in transcription factor binding. PLoS Genet. 2014, 10:e1004226.
15. De Beaufort C.E., Lange K., Swift P.G.F., et al. Metabolic outcomes in young children with type 1 diabetes differ between treatment centers: the Hvidoere study in young children 2009. Pediatr. Diabetes 2013, 14:422-428.
16. Derrien T., Johnson R., Bussotti G., et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012, 22:1775-1789.
17. Eizirik D.L., Sammeth M., Bouckenooghe T., et al. The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. PLoS Genet. 2012, 8:e1002552.
18. Elghazi L., Bernal-Mizrachi E. Akt and PTEN: beta-cell mass and pancreas plasticity. Trends Endocrinol. Metab. 2009, 20:243-251.
19. Espino-Paisan L., de la Calle H., Fernández-Arquero M., et al. Polymorphisms in chromosome region 12q13 and their influence on age at onset of type 1 diabetes. Diabetologia 2011, 54:2033-2037.
20. Fløyel T., Brorsson C., Nielsen L.B., et al. CTSH regulates β-cell function and disease progression in newly diagnosed type 1 diabetes patients. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:10305-10310.
21. Gentleman R.C., Carey V.J., Bates D.M., et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004, 5:R80. 10.1186/gb-2004-5-10-r80.
22. GTEx Consortium Human genomics. The genotype-tissue expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 2015, 348(6235):648-660.
23. Guay C., Regazzi R. Circulating microRNAs as novel biomarkers for diabetes mellitus. Nat. Rev. Endocrinol. 2013, 9:513-521.
24. Hakonarson H., Qu H.-Q., Bradfield J.P., et al. A novel susceptibility locus for type 1 diabetes on Chr12q13 identified by a genome-wide association study. Diabetes 2008, 57:1143-1146.
25. Harrow J., Frankish A., Gonzalez J.M., et al. GENCODE: the reference human genome annotation for the ENCODE Project. Genome Res. 2012, 22:1760-1774.
26. Hezova R., Slaby O., Faltejskova P., et al. microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients. Cell. Immunol. 2010, 260:70-74.
27. Johnson A.D., Handsaker R.E., Pulit S.L., et al. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 2008, 24:2938-2939.
28. Keene K.L., Quinlan A.R., Hou X., et al. Evidence for two independent associations with type 1 diabetes at the 12q13 locus. Genes Immun. 2012, 13:66-70.
29. Kornienko A.E., Guenzl P.M., Barlow D.P., Pauler F.M. Gene regulation by the act of long non-coding RNA transcription. BMC Biol. 2013, 11:59.
30. Lee D., Yu M., Lee E., et al. Tumor-specific apoptosis caused by deletion of the ERBB3 pseudo-kinase in mouse intestinal epithelium. J. Clin. Invest. 2009, 119:2702-2713.
31. Lee H.S., Cho H.J., Kwon G.T., Park J.H.Y. Kaempferol downregulates insulin-like growth factor-i receptor and ErbB3 signaling in HT-29 human colon cancer cells. J. Cancer Prev. 2014, 19:161-169.
32. Lee H., Lee H., Chin H., et al. ERBB3 knockdown induces cell cycle arrest and activation of Bak and Bax-dependent apoptosis in colon cancer cells. Oncotarget 2014, 5:5138-5152.
33. Li J.-H., Liu S., Zhou H., et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014, 42:D92-D97.
34. Max Andersen M.L.C., Hougaard P., Pörksen S., et al. Partial remission definition: validation based on the insulin dose-adjusted HbA1c (IDAA1C) in 129 Danish children with new-onset type 1 diabetes. Pediatr. Diabetes 2014, 15:469-476.
35. Mirza A.H., Kaur S., Brorsson C.A., Pociot F. Effects of GWAS-associated genetic variants on lncRNAs within IBD and T1D candidate loci. PLoS One 2014, 9:e105723.
36. Olayioye M.A., Neve R.M., Lane H.A., Hynes N.E. The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J. 2000, 19:3159-3167.
37. Onengut-Gumuscu S., Chen W.-M., Burren O., et al. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. Nat. Genet. 2015, 47:381-386. 10.1038/ng.3245.
38. Perocchi F., Xu Z., Clauder-Münster S., Steinmetz L.M. Antisense artifacts in transcriptome microarray experiments are resolved by actinomycin D. Nucleic Acids Res. 2007, 35:e128.
39. Pullen T., Rutter G. An islet-specific long non-coding RNA (lncRNA) expressed from the Pdx1 locus regulates Pdx1 activity. Diabetologia 2012, 55:212.
40. Romanos J., Wijmenga C. Comment on: Barker et al. (2008) Two single nucleotide polymorphisms identify the highest-risk diabetes HLA genotype. Diabetes 2009, 57:3152-3155. 2008. Diabetes 58:e1; author reply e2.
41. Rosenbloom K.R., Sloan C.A., Malladi V.S., et al. ENCODE data in the UCSC Genome Browser: year 5 update. Nucleic Acids Res. 2013, 41:D56-D63.
42. Schaub M.A., Boyle A.P., Kundaje A., et al. Linking disease associations with regulatory information in the human genome. Genome Res. 2012, 22:1748-1759.
43. Schulthess F.T., Paroni F., Sauter N.S., et al. CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling. Cell Metab. 2009, 9:125-139.
44. Stark C., Breitkreutz B.-J., Reguly T., et al. BioGRID: a general repository for interaction datasets. Nucleic Acids Res. 2006, 34:D535-D539.
45. Stranger B.E., Montgomery S.B., Dimas A.S., et al. Patterns of cis regulatory variation in diverse human populations. PLoS Genet. 2012, 8:e1002639.
46. Todd J.A., Walker N.M., Cooper J.D., et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat. Genet. 2007, 39:857-864.
47. Törn C., Hadley D., Lee H.-S., et al. Role of type 1 diabetes-associated SNPs on risk of autoantibody positivity in the TEDDY study. Diabetes 2015, 64:1818-1829.
48. Tsui S., Dai W., Lu L. CCCTC-binding factor mediates effects of glucose on beta cell survival. Cell Prolif. 2014, 47:28-37.
49. Wang H., Jin Y., Reddy M.V.P.L., et al. Genetically dependent ERBB3 expression modulates antigen presenting cell function and type 1 diabetes risk. PLoS One 2010, 5:e11789.
50. Westra H.-J., Peters M.J., Esko T., et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat. Genet. 2013, 45:1238-1243.
51. Wilusz J.E., Sunwoo H., Spector D.L. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev. 2009, 23:1494-1504.
52. Winkler C., Krumsiek J., Lempainen J., et al. A strategy for combining minor genetic susceptibility genes to improve prediction of disease in type 1 diabetes. Genes Immun. 2012, 13:549-555.
53. Xie C., Yuan J., Li H., et al. NONCODEv4: exploring the world of long non-coding RNA genes. Nucleic Acids Res. 2014, 42:D98-D103.
54. Xu Z., Wei W., Gagneur J., et al. Antisense expression increases gene expression variability and locus interdependency. Mol. Syst. Biol. 2011, 7:468.